Apolipoprotein A-I and paraoxonase-1 are potential blood biomarkers for ischemic stroke diagnosis

Journal of Stroke and Cerebrovascular Diseases

Volumn 25, Issue 6, 2016, Pages 1360-1365

  Walsh, Kyle B ^a,b   Hart, Kimberly ^b   Roll, Susan ^b   Sperling, Matthew ^b   Unruh, Dusten ^b   Davidson, W Sean ^c   Lindsell, Christopher J ^b   Adeoye, Opeolu ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

biomarker; diagnosis; intracerebral hemorrhage; Ischemic stroke; plasma; proteomics

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN C1; APOLIPOPROTEIN C3; ARYLDIALKYLPHOSPHATASE 1; BIOLOGICAL MARKER; GELATINASE B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; STROMELYSIN; APOA1 PROTEIN, HUMAN; ARYLDIALKYLPHOSPHATASE; PON1 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; AGED; BLOOD; CEREBRAL HEMORRHAGE; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; OHIO; PREDICTIVE VALUE; STROKE;

AGED; APOLIPOPROTEIN A-I; ARYLDIALKYLPHOSPHATASE; BIOMARKERS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OHIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; STROKE;

EID: 84961122191     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2016.02.027     Document Type: Article

References (33)

1. D. Mozaffarian, E.J. Benjamin, A.S. Go, and et al. Heart disease and stroke statistics - 2015 update: a report from the American Heart Association Circulation 131 2015 e29 e322
2. A.M. Nor, J. Davis, B. Sen, and et al. The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument Lancet Neurol 4 2005 727 734
3. N.M. Lever, K.V. Nystrom, J.L. Schindler, and et al. Missed opportunities for recognition of ischemic stroke in the emergency department J Emerg Nurs 39 2013 434 439
4. O. Adeoye, K.C. Albright, B.G. Carr, and et al. Geographic access to acute stroke care in the United States Stroke 45 2014 3019 3024
5. P. Kodali, K.R. Chitta, J.A. Landero Figueroa, and et al. Detection of metals and metalloproteins in the plasma of stroke patients by mass spectrometry methods Metallomics 4 2012 1077 1087
6. K. Ranade, T.G. Kirchgessner, O.A. Iakoubova, and et al. Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke Stroke 36 2005 2346 2350
7. N.S. Kim, Kang K., M.H. Cha, and et al. Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans Biochem Biophys Res Commun 364 2007 157 162
8. E.M. Kim, and O. Hwang Role of matrix metalloproteinase-3 in neurodegeneration J Neurochem 116 2011 22 32
9. S.K. Kim, Kang S.W., D.H. Kim, and et al. Matrix metalloproteinase-3 gene polymorphisms are associated with ischemic stroke J Interferon Cytokine Res 32 2012 81 86
10. K.J. Gurney, E.Y. Estrada, and G.A. Rosenberg Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation Neurobiol Dis 23 2006 87 96
11. E. Cuadrado, A. Rosell, A. Penalba, and et al. Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study J Proteome Res 8 2009 3191 3197
12. A.W. Clark, C.A. Krekoski, S.S. Bou, and et al. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia Neurosci Lett 238 1997 53 56
13. M. Castellanos, R. Leira, J. Serena, and et al. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke Stroke 34 2003 40 46
14. L. Allard, P. Lescuyer, J. Burgess, and et al. ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke Proteomics 4 2004 2242 2251
15. M.F. Lopez, D.A. Sarracino, A. Prakash, and et al. Discrimination of ischemic and hemorrhagic strokes using a multiplexed, mass spectrometry-based assay for serum apolipoproteins coupled to multi-marker ROC algorithm Proteomics Clin Appl 6 2012 190 200
16. S. As, S. Sahukar, J. Murthy, and et al. A study of serum apolipoprotein A1, apolipoprotein B and lipid profile in stroke J Clin Diagn Res 7 2013 1303 1306
17. D.G. Bonett, and R.M. Price Statistical inference for a linear function of medians: confidence intervals, hypothesis testing, and sample size requirements Psychol Methods 7 2002 370 383
18. A. Eklund The bee swarm plot, an alternative to stripchart R Package Version 0.1.6 2013
19. G. Walldius, and I. Jungner Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke Curr Opin Cardiol 22 2007 359 367
20. G. Walldius, A.H. Aastveit, and I. Jungner Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study J Intern Med 259 2006 259 266
21. N. Koren-Morag, U. Goldbourt, E. Graff, and et al. Apolipoproteins B and AI and the risk of ischemic cerebrovascular events in patients with pre-existing atherothrombotic disease J Neurol Sci 270 2008 82 87
22. J. Bjorkegren Dual roles of apolipoprotein CI in the formation of atherogenic remnants Curr Atheroscler Rep 8 2006 1 2
23. P.J. Barter, S. Nicholls, K.A. Rye, and et al. Antiinflammatory properties of HDL Circ Res 95 2004 764 772
24. I. Korita, A. Bulo, M.R. Langlois, and et al. Serum amyloid A is independently related to apolipoprotein A-I but not to HDL-cholesterol in patients with angina pectoris Clin Biochem 46 2013 1660 1663
25. Wang D.X., Liu H., Yan L.R., and et al. The relationship between serum amyloid A and apolipoprotein A-I in high-density lipoprotein isolated from patients with coronary heart disease Chin Med J 126 2013 3656 3661
26. P.J. Pussinen, E. Malle, J. Metso, and et al. Acute-phase HDL in phospholipid transfer protein (PLTP)-mediated HDL conversion Atherosclerosis 155 2001 297 305
27. Chen S., Yang Q., Chen G., and et al. An update on inflammation in the acute phase of intracerebral hemorrhage Transl Stroke Res 6 2015 4 8
28. D. Klebe, D. McBride, J.J. Flores, and et al. Modulating the immune response towards a neuroregenerative peri-injury milieu after cerebral hemorrhage J Neuroimmune Pharmacol 10 2015 576 586
29. B. Coull Inflammation and stroke introduction Stroke 38 2007 631
30. P.J. Lindsberg, and A.J. Grau Inflammation and infections as risk factors for ischemic stroke Stroke 34 2003 2518 2532
31. T. Dziedzic Systemic inflammation as a therapeutic target in acute ischemic stroke Expert Rev Neurother 15 2015 523 531
32. C.E. Furlong, S.M. Suzuki, R.C. Stevens, and et al. Human PON1, a biomarker of risk of disease and exposure Chem Biol Interact 187 2010 355 361
33. R. Movva, and D.J. Rader Laboratory assessment of HDL heterogeneity and function Clin Chem 54 2008 788 800